This federal contract award SPE2DB24D1007|SPE2DB25FBZTA, with a ceiling value of $6,405.68, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Eliquis 5 mg tablet 60s, a pharmaceutical product, to support military healthcare programs.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare agencies, particularly the DLA. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
This specific delivery order contract does not have a set-aside designation, indicating open competition. The award date is December 23, 2024, and the ultimate completion date is December 24, 2024, suggesting a short-term, targeted procurement of the Eliquis medication. Amerisourcebergen's extensive experience in supplying pharmaceutical and medical products to federal agencies, including the DLA and the Department of Justice Federal Bureau of Investigation, positions the company as a reliable partner in fulfilling the government's healthcare needs.
Generated 3/24/25, 9:54 AM